PLA2G7 and atherosclerosis: Given Lp-PLA2’s role as a key modulator of oxidative stress, inflammation, and atherosclerosis [13] and that it overlaps with the effects of Danshen therapy [14], Danshen likely works through lowering Lp-PLA2 levels to achieve its efficacy in inhibiting oxidative stress and inflammation.